1. Home
  2. ADTX vs SPRC Comparison

ADTX vs SPRC Comparison

Compare ADTX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADTX
  • SPRC
  • Stock Information
  • Founded
  • ADTX 2017
  • SPRC 2004
  • Country
  • ADTX United States
  • SPRC Israel
  • Employees
  • ADTX N/A
  • SPRC N/A
  • Industry
  • ADTX Biotechnology: Pharmaceutical Preparations
  • SPRC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADTX Health Care
  • SPRC Health Care
  • Exchange
  • ADTX Nasdaq
  • SPRC Nasdaq
  • Market Cap
  • ADTX 3.1M
  • SPRC 3.4M
  • IPO Year
  • ADTX 2020
  • SPRC N/A
  • Fundamental
  • Price
  • ADTX $1.21
  • SPRC $0.31
  • Analyst Decision
  • ADTX
  • SPRC
  • Analyst Count
  • ADTX 0
  • SPRC 0
  • Target Price
  • ADTX N/A
  • SPRC N/A
  • AVG Volume (30 Days)
  • ADTX 1.2M
  • SPRC 198.5K
  • Earning Date
  • ADTX 08-18-2025
  • SPRC 02-15-2025
  • Dividend Yield
  • ADTX N/A
  • SPRC N/A
  • EPS Growth
  • ADTX N/A
  • SPRC N/A
  • EPS
  • ADTX N/A
  • SPRC N/A
  • Revenue
  • ADTX $55,323.00
  • SPRC $1,306,000.00
  • Revenue This Year
  • ADTX $15,768.94
  • SPRC N/A
  • Revenue Next Year
  • ADTX N/A
  • SPRC N/A
  • P/E Ratio
  • ADTX N/A
  • SPRC N/A
  • Revenue Growth
  • ADTX N/A
  • SPRC N/A
  • 52 Week Low
  • ADTX $1.11
  • SPRC $0.20
  • 52 Week High
  • ADTX $27,200.00
  • SPRC $1.79
  • Technical
  • Relative Strength Index (RSI)
  • ADTX 34.54
  • SPRC 50.45
  • Support Level
  • ADTX $1.28
  • SPRC $0.29
  • Resistance Level
  • ADTX $2.19
  • SPRC $0.32
  • Average True Range (ATR)
  • ADTX 0.17
  • SPRC 0.02
  • MACD
  • ADTX 0.04
  • SPRC -0.00
  • Stochastic Oscillator
  • ADTX 9.26
  • SPRC 46.00

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: